Sign in
MSLE Stock Price, Chart, Stats & News
Satellos Bioscience Inc. Common Stock
Save
7.33M
Market cap
–
Current P/E
–
Forward P/E
MSLE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.55% |
ROA | -55.65% |
ROE | -51.76% |
D/E | – |
Interest coverage ratio | – |
MSLE valuation
P/E | – |
P/S | – |
P/B | 2.54x |
P/CF | -4.10x |
P/FCF | -0.38x |
P/OCF | -4.10x |
PEG | -0.18x |
EV multiple | -1.23x |
About
Satellos Bioscience, Inc. is a regenerative medicine firm dedicated to creating novel therapeutic solutions. The company employs its proprietary MyoReGenX™ technology platform, which enables the identification of stem cell regeneration deficits within various muscle diseases and subsequently facilitates the development of targeted treatments. Frank Gleeson and Michael Rudnicki established the company on July 27, 2012, and its corporate headquarters are located in Toronto, Canada.
Similar securities
Based on sector and market capitalization
Report issue